Skip to main content
. Author manuscript; available in PMC: 2011 Feb 1.
Published in final edited form as: Cancer Res. 2010 Jan 19;70(3):1072. doi: 10.1158/0008-5472.CAN-09-1301

Figure 2.

Figure 2

DCAd.Neu+Ad.mIL-15+Ad.mIL-15Rα vaccination of BALB-neuT mice significantly delayed or prevented the onset of mammary tumors. Groups (n =10) of 12-week-old female BALB-neuT mice received four weekly subcutaneous injections of 1 × 106 DCAd.Neu, DCAd.Neu+Ad.mIL-15, DCAd.Neu+Ad.mIL-15Rα, DCAd.Neu+Ad.mIL-15+Ad.mIL-15Rα, DCAd.mIL-15+Ad.mIL-15Rα or DCAd.null. Mice were examined twice weekly for the formation of mammary tumors.